Summary & Overview
CPT 84512: Troponin Detection Assay in Blood
CPT code 84512 represents a laboratory assay to detect troponin in patient blood, a critical diagnostic marker for myocardial injury and ischemia. Nationally, troponin testing is central to emergency and inpatient cardiology workflows and influences acute care triage, diagnostic pathways, and downstream resource use. The code reflects a commonly ordered clinical laboratory service with implications for hospital and outpatient laboratory billing practices.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for troponin testing, typical sites of service where 84512 is billed, and what to expect in payer coverage patterns. The publication also outlines benchmarks and billing considerations relevant to laboratories and hospital revenue cycle teams, plus any notable policy updates affecting clinical laboratory reimbursement.
This summary equips clinical laboratory managers, billing professionals, and policy analysts with a clear understanding of the clinical purpose of CPT code 84512, the payer landscape addressed, and the types of operational and policy information included in the full publication.
Billing Code Overview
CPT code 84512 describes a laboratory assay performed to detect the presence of troponin in a patient's blood. This test measures cardiac troponin proteins that indicate myocardial injury and is commonly used in the evaluation of chest pain and suspected acute coronary syndrome.
Service type: Clinical laboratory diagnostic test
Typical site of service: Hospital laboratory, outpatient laboratory, emergency department-associated lab, or other certified clinical laboratory facility
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old male presents to the emergency department with acute-onset chest pressure, diaphoresis, and shortness of breath that began one hour prior to arrival. Emergency triage obtains vital signs and places the patient on continuous cardiac monitoring. An initial 12-lead ECG is performed, and the clinician orders stat cardiac biomarkers, including troponin testing, to evaluate for acute myocardial injury.
Blood is drawn by phlebotomy and sent to the hospital laboratory. The lab analyst performs a troponin assay per protocol using immunoassay instrumentation. Results are reported as a numeric value with the assay’s reference range and flagged if above the laboratory’s 99th percentile cutoff. The clinician interprets troponin trends with serial testing (typically at presentation and 3–6 hours later) to determine whether there is evidence of myocardial infarction, ongoing ischemia, or nonischemic myocardial injury. The test result guides decisions about cardiology consultation, admission vs discharge, and further diagnostic testing such as coronary angiography or stress testing.
Typical site of service: Hospital outpatient department, emergency department, or an independent clinical laboratory performing STAT or routine troponin assays.
Service type: Laboratory diagnostic test (troponin immunoassay) performed by a clinical laboratory analyst under clinical laboratory improvement amendments (CLIA) regulations.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 |